Clinical trials: Unspecified Condition Associated With Female Genital Organs and Menstrual Cycle
Myoma;Uterus, Polyp Endometrium
Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
Remimazolam is a novel drug approved for induction and maintenance of general anesthesia. This study aims to check the appropriate dose and patient response by administering remimazolam and remifentanil in surgery that does not…
- Conditions
- Myoma;Uterus, Polyp Endometrium, Unspecified Condition Associated With Female Genital Organs and Menstrual Cycle
- Trial name
- NCT05025410
- Testing
- Remimazolam
- Where
- South Korea
- Volunteers
- 38 people
- Sponsor
- Seoul National University Bundang Hospital